Abstract
Chronic hepatitis B (CHB) remains a significant epidemiological and clinical challenge in global healthcare. According to the World Health Organization, more than 250 million people worldwide live with this infection, and approximately 800,000 deaths annually are associated with liver cirrhosis and hepatocellular carcinoma.
References
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2026 World Conference on Social Sciences, Law and Public Policy